LOGO.jpg
Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials
June 28, 2024 10:15 ET | Vivos Inc.
Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing...